Home
Scholarly Works
2022-RA-744-ESGO Hepatitis B screening to reduce...
Conference

2022-RA-744-ESGO Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer centre: a quality improvement initiative

Authors

Mah SJ; Bellini J; Zhao L; van Nguyen JM; Reade CJ; Jimenez W; Carlson V; Tyagi NK; Bernard L; Pond G

Volume

32

Publisher

Elsevier

Publication Date

October 1, 2022

DOI

10.1136/ijgc-2022-esgo.405

Conference proceedings

International Journal of Gynecological Cancer

ISSN

1048-891X

Contact the Experts team